Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res
✦ LIBER ✦
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C
✍ Scribed by Patrick Marcellin; Michèle Pouteau; Michèle Martinot-Peignoux; Françoise Degos; Véronique Duchatelle; Nathalie Boyer; Catherine Lemonnier; Claude Degott; Serge Erlinger; Jean Pierre Benhamou
- Book ID
- 118881841
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 936 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Re-treatment with interferon alfa of pat
✍
Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 95 KB
👁 2 views
Lack of benefit of prolonging interferon
✍
M. Pouteau; M. Martinot; N. Boyer; S. Erlinger; P. Marcellin
📂
Article
📅
1998
🏛
Elsevier Science
🌐
English
⚖ 161 KB
Incidence of interferon alfa–induced dep
✍
Laurent Castéra; Franck Zigante; Anne Bastie; Catherine Buffet; Daniel Dhumeaux;
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 106 KB
Pretreatment Prediction of Interferon-Al
✍
Hayashida, Kazuhiro; Daiba, Akito; Sakai, Akito; Tanaka, Takeshi; Kaji, Kyosuke;
📂
Article
📅
2005
🏛
Elsevier Science
🌐
English
⚖ 103 KB
Retreatment of chronic hepatitis C patie
✍
Boris Vucelic; Irena Hrstic; Rajko Ostojic; Nadan Rustemovic; Milorad Opacic; Ve
📂
Article
📅
2002
🏛
Elsevier Science
🌐
English
⚖ 103 KB
Serum levels of hepatitis C virus core p
✍
E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha
📂
Article
📅
1996
🏛
John Wiley and Sons
🌐
English
⚖ 205 KB
👁 2 views
The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa